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Introduction
The scientific information on biological activity of ceria
dioxide nanoparticles (CeO2, nanoceria) is still very frag-
mentary. It is known, that nanoceria interaction with
biological systems is based on two principal properties
of this substance: low toxicity and high reducibility [1].
These factors determines activity of nanoceria in biolo-
gical redox processes, especially in inactivation of reac-
tive oxygen species, including free radicals that are
formed inside living cells.
The aim
of the study was to assess the perspectives of nanoceria
for various biomedical applications.
Methods
We have performed series of studies to investigate the bio-
medical effects of nanoceria in vitro and in vivo. Effectivity
of ceria nanoparticles after UV-irradiation was determined
by the analysis of L929 and VERO cells Viability State of
the cells were visualized under UV microscope using
fluorescent Hoechst and Propidium iodide dyes. Investi-
gated the effects on reproduction nanoceria VSV (RNA-)
and HSV-1 (DNA-) viruses, the viability of E.coli, S.aureus
and C.albicans. We studied the effects of nanoceria doxor-
ubicin-induced ultrasonography guided cardiomyopathy
model and on the reproductive system of older animals.
Results
We estimated that 1, 25 mM colloid ceria solutions are
capable to protect L929 and VERO cells from the damage
induced by UV-irradiation [1,2]. Nanoceria could be used
not only as UV-blocking material, but also as prophylactic
and even therapeutic compound for treatment sunburns.
We consider that nanoceria inhibits the reproduction of
the studied RNA-and DNA-viruses in and demonstrates a
significant virucidal effect [3], reducing the virus titer in
the investigated model systems. We have shown the anti-
bacterial activity for gram-positive microorganisms and
expressive antifungal action [4]. Course reception of nano-
ceria by older laboratory animals (mice / rats) causes
improvement in the viability of germ cells in males
increases the level of testosterone in the blood, protect
ovarian cells against oxidative damage [5], demonstrating
anti-aging properties. Application of nanoceria against
doxorubicin-induced cardiomyopathy on reliable model
[6] can remove the drug-induced oxidative stress, restoring
the broken functionality of the body.
Conclusion
The application of nanoceria under conditions of involving
oxidative stress can reduce / remove its damaging effects,
thus providing protecting the organism from adverse
environmental factors: UV irradiation, viral, bacterial, fun-
gal lesions induced toxic effects and pathological condi-
tions associated with aging.
Outlook and expert recommendations
The biomedical effects of nanoceria offer the prospect of
its use as a UV protectant, a drug with antiviral, antibac-
terial and antifungal activity, as well as means capable of
reducing the level of oxidative stress in cardiomyocytes
in reproductive organs during aging.
Authors’ details
1D.K. Zabolotny Institute of microbiology and virology NAS of Ukraine, Kyiv,
Ukraine. 2Clinical hospital “Pheophania” of State Affairs Department, Kyiv,
* Correspondence: rostbubnov@gmail.com
† Contributed equally
1D.K. Zabolotny Institute of microbiology and virology NAS of Ukraine, Kyiv,
Ukraine
Full list of author information is available at the end of the article
Zholobak et al. EPMA Journal 2014, 5(Suppl 1):A136
http://www.epmajournal.com/content/5/S1/A136
© 2014 Zholobak et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ukraine. 3Kurnakov institute of general and inorganic Chemistry of Russian
Academy of Sciences, Moscow, Russia.
Published: 11 February 2014
References
1. Shcherbakov AB, Ivanov VK, Zholobak NM, Ivanova OS, Krysanov EIu,
Baranchikov AE: Nanocrystaline ceria based materials-perspectives for
biomedical application. Biofizika 2011, 56(6):995-1015.
2. Zholobak NM, Ivanov VK, Shcherbakov AB, Shaporev AS, Polezhaeva OS,
Baranchikov AYe, Spivak NYa, Tretyakov YuD: UV-shielding property,
photocatalytic activity and photocytotoxicity of ceria colloid solutions. J.
Photochem. Photobiol. B 2011, 102:P32-38.
3. Zholobak N, Sherbakov A, Ivanov V, Olevinskaya Z, Spivak N: Antiviral
effectivity of ceria colloid colutions Antiviral Research. In Twenty-Fourth
International Conference on Antiviral Research. Volume 90. Sofia, Bulgaria;
2011:(2):A67.
4. Babenko LP, Zholobak NM, Shcherbakov AB, Woychuk SI, Lazarenko LM,
Spivak MYa: Antimicrobial action of the ceria colloid solution on
opportunistic microorganisms in vitro. Mikrobiol 2012, 74(3):54-62.
5. Spivak Ya, Shepel EA, Zholobak NM, Sherbakov AB, Antonovitch GV,
Yanciy RV, Ivanov VK, Tretyakov YuD: Ceria nanoparticles boost activity of
aged murine oocytes. NanoBiomed Eng 2012, 4(4):188-194.
6. Bubnov RV: The Use of Ultrasound Equipment of General Use for In Vivo
Study of Cerium Dioxide Nanoparticles Introduction in Mice. Ultrasound
Med Biol 2011, 37(8):S162, Suppl. 1.
doi:10.1186/1878-5085-5-S1-A136
Cite this article as: Zholobak et al.: The perspectives of biomedical
application of the nanoceria. EPMA Journal 2014 5(Suppl 1):A136.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zholobak et al. EPMA Journal 2014, 5(Suppl 1):A136
http://www.epmajournal.com/content/5/S1/A136
Page 2 of 2
